Andrew Smith is an accomplished executive leader with over 30 years’ international experience within the bio-pharma sector.

He currently serves as Chief Financial Officer for Santhera Pharmaceuticals AG, a global specialty pharmaceutical company focused on developing medicines for rare diseases. Before joining Santhera he held the roles of CFO and COO Allecra Therapeutics GmbH and CFO at Sucampo Pharmaceuticals Inc.. Together with previous senior financial and operations roles focusing on business improvement and transformation he has gained significant exposure to European and US markets working in public and private organizations with a focus on start-ups, spinoffs and growth and has been involved in a number of capital market transactions in excess of USD 700 million.

Andrew is a Fellow of the Chartered Institute of Management Accountants and a Chartered Global Management Accountant.

He studied business and accounting at Liverpool John Moores University and Durham University Business School.

Andrew joined the Arix Board in August 2022 and is Chair of the Audit Committee and a member of the Nomination Committee.